Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gibiansky

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|August 1, 1996
The variance of a better AUC estimator for sparse, destructive sampling in toxicokineticsJ R Nedelman, E Gibiansky
Pharmaceutical Research|January 1, 1995
Applying Bailer's method for AUC confidence intervals to sparse samplingJ R Nedelman, E Gibiansky, D T Lau
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1993
Assessing drug exposure in rodent toxicity studies without satellite animalsJ R Nedelman, E Gibiansky, F L Tse, et al.
Pharmaceutical Research|September 1, 1996
Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studiesS M Pai, J R Nedelman, G Hajian, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1997
Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modelingJ R Nedelman, E Gibiansky, J Cramer, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 30, 2014
Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure-Response in CLLE Gibiansky, L Gibiansky, D J Carlile, et al.
Statistics in Medicine|May 15, 1995
Inferring systemic exposure from a pharmacokinetic screen: model-free and model-based approachesJ R Nedelman, A H Karara, C T Chang, et al.
Biopharmaceutics & Drug Disposition|March 1, 1997
The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjectsJ Nedelman, J A Cramer, B Robbins, et al.
Journal of Clinical Pharmacology|May 1, 1996
Pharmacokinetics and pharmacodynamics of multiple-dose terbinafineJ R Nedelman, E Gibiansky, B A Robbins, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2001
Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosisJ S Barrett, E Gibiansky, R D Hull, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|August 1, 1996
The variance of a better AUC estimator for sparse, destructive sampling in toxicokineticsJ R Nedelman, E Gibiansky
Pharmaceutical Research|January 1, 1995
Applying Bailer's method for AUC confidence intervals to sparse samplingJ R Nedelman, E Gibiansky, D T Lau
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1993
Assessing drug exposure in rodent toxicity studies without satellite animalsJ R Nedelman, E Gibiansky, F L Tse, et al.
Pharmaceutical Research|September 1, 1996
Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studiesS M Pai, J R Nedelman, G Hajian, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1997
Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modelingJ R Nedelman, E Gibiansky, J Cramer, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 30, 2014
Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure-Response in CLLE Gibiansky, L Gibiansky, D J Carlile, et al.
Statistics in Medicine|May 15, 1995
Inferring systemic exposure from a pharmacokinetic screen: model-free and model-based approachesJ R Nedelman, A H Karara, C T Chang, et al.
Biopharmaceutics & Drug Disposition|March 1, 1997
The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjectsJ Nedelman, J A Cramer, B Robbins, et al.
Journal of Clinical Pharmacology|May 1, 1996
Pharmacokinetics and pharmacodynamics of multiple-dose terbinafineJ R Nedelman, E Gibiansky, B A Robbins, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2001
Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosisJ S Barrett, E Gibiansky, R D Hull, et al.
Pageof 2